This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Innate Pharma. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Silvia Parolini: Innovator in Antibody Development
Introduction
Silvia Parolini is a prominent inventor based in Brescia, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 2 patents, her work focuses on addressing critical health challenges.
Latest Patents
Silvia's latest patents include the development of Anti-KIR3D antibodies. These inventions provide antigen-binding proteins capable of binding to KIR3D polypeptides. The antibodies demonstrate increased activity in treating disorders characterized by KIR3DL2-expressing cells, particularly CD4+ T cells. This includes malignancies such as Mycosis Fungoides and Sézary Syndrome.
Career Highlights
Silvia Parolini is associated with Innate Pharma, a company dedicated to advancing cancer immunotherapy. Her work at Innate Pharma has positioned her as a key player in the field of therapeutic antibody development.
Collaborations
Some of her notable coworkers include Nicolas Anfossi and Laurent Gauthier. Their collaborative efforts contribute to the innovative research and development at Innate Pharma.
Conclusion
Silvia Parolini's contributions to antibody development are paving the way for new treatments in oncology. Her innovative spirit and dedication to research continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile